Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Janux Therapeutics Inc shares valued at $106,745 were sold by Meyer Andrew Hollman on May 01 ’25. At $32.03 per share, Meyer Andrew Hollman sold 3,333 shares. The insider’s holdings dropped to 82,139 shares worth approximately $1.91 million following the completion of this transaction.
Also, ANDREW MEYER purchased 3,333 shares, netting a total of over 110,656 in proceeds.
Before that, Meyer Andrew Hollman had sold 3,334 shares from its account. In a trade valued at $100,020, the Chief Business Officer traded Janux Therapeutics Inc shares for $30.00 each. Upon closing the transaction, the insider’s holdings decreased to 3,334 shares, worth approximately $1.91 million.
As published in a research note from H.C. Wainwright on December 03, 2024, Janux Therapeutics Inc [JANX] has been retained to a Buy and the price target has been revised to $70. Analysts at BTIG Research resumed the stock at ‘”a Buy”‘ outlook in a report released in early December. As of November 22, 2024, Leerink Partners has initiated its “an Outperform” rating for JANX. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Buy” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a drop of approximately -11.76%. Over the course of the year, Janux Therapeutics Inc shares have dropped approximately -56.54%. Shares of the company reached a 52-week high of $61.59 on 01/07/25 and a 52-week low of $22.48 on 05/14/25. A 50-day SMA is recorded $28.98, while a 200-day SMA reached $42.38.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 22.54, which, if violated, would cause prices to drop to 21.80. In the upper region, resistance lies at 23.99. The next price resistance is at 24.70. RSI (Relative Strength Index) is 33.94 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.34, which suggests the price will decrease in the coming days. Percent R is at 93.12%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
